Cargando…
Intravitreal administration of recombinant human opticin protects against hyperoxia-induced pre-retinal neovascularization
Opticin is an extracellular glycoprotein present in the vitreous. Its antiangiogenic properties offer the potential for therapeutic intervention in conditions such as proliferative diabetic retinopathy and retinopathy of prematurity. Here, we investigated the hypothesis that intravitreal administrat...
Autores principales: | Klaska, Izabela P., White, Anne, Villacampa, Pilar, Hoke, Justin, Abelleira-Hervas, Laura, Maswood, Ryea N., Ali, Robin R., Bunce, Catey, Unwin, Richard D., Cooper, Garth J.S., Bishop, Paul N., Bainbridge, James W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935380/ https://www.ncbi.nlm.nih.gov/pubmed/34954204 http://dx.doi.org/10.1016/j.exer.2021.108908 |
Ejemplares similares
-
Intravitreal Pharmacokinetic Study of the Antiangiogenic
Glycoprotein Opticin
por: del Amo, Eva M., et al.
Publicado: (2020) -
Opticin Exerts Its Anti-angiogenic Activity by Regulating Extracellular Matrix Adhesiveness
por: Le Goff, Magali M., et al.
Publicado: (2012) -
Opticin: a potent anti-angiogenic/antiproliferative agent for breast cancer therapy
por: Sneddon, SF, et al.
Publicado: (2010) -
In vivo effect of opticin deficiency in cartilage in a surgically induced mouse model of osteoarthritis
por: Farrán, Aina, et al.
Publicado: (2018) -
Accelerated oxygen-induced retinopathy is a reliable model of ischemia-induced retinal neovascularization
por: Villacampa, Pilar, et al.
Publicado: (2017)